Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/19/2011 | EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
01/19/2011 | EP2275547A2 Polynucleotides and polypeptide sequences involved in the process of bonne remodeling |
01/19/2011 | EP2275544A2 Genes and polypeptides relating to human colon cancers |
01/19/2011 | EP2275541A2 Method for controlling the activity of immunologically functional molecule |
01/19/2011 | EP2275540A2 Method for controlling the activity of immunologically functional molecule |
01/19/2011 | EP2275537A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
01/19/2011 | EP2275450A1 Treatment with anti-ERBB2 antibodies |
01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
01/19/2011 | EP2275448A2 Monovalent antibody fragments useful as therapeutics |
01/19/2011 | EP2275447A1 Methods of inhibiting metastasis |
01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |
01/19/2011 | EP2275445A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
01/19/2011 | EP2275444A1 Chimeric anti CD44 antibodies and their use for treating acute myeloid leukemia |
01/19/2011 | EP2275443A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
01/19/2011 | EP2275442A1 Detection and vizualization of the cell cycle in living cells |
01/19/2011 | EP2275435A2 Streptococcus agalactiae antigens I + II |
01/19/2011 | EP2275136A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
01/19/2011 | EP2275135A1 Therapeutic for hepatic cancer |
01/19/2011 | EP2275134A2 Use of ADCC-optimized antibodies for treating weak patients |
01/19/2011 | EP2275116A1 Use of a Pak inhibitor for the treatment of a joint disease |
01/19/2011 | EP2274437A2 Compositions and methods for detecting egfr mutations in cancer |
01/19/2011 | EP2274335A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
01/19/2011 | EP2274334A2 Neutralizing molecules to viral antigens |
01/19/2011 | EP2274333A2 Methods for treating psoriasis |
01/19/2011 | EP2274332A1 Anti-tnf antibody |
01/19/2011 | EP2274331A1 Improved fibronectin-based binding molecules and uses thereof |
01/19/2011 | EP2274012A1 Cytotoxic immunoglobulin |
01/19/2011 | EP2274011A2 An antibody bound synthetic vesicle containing active agent molecules |
01/19/2011 | EP2274009A2 Methods of treatment |
01/19/2011 | EP2274008A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
01/19/2011 | EP1668036B1 Method for the production of human antibodies blocking the biological activity of a human cytokine |
01/19/2011 | EP1556071B1 Methods to prevent tumor recurrence by blockade of tgf-beta |
01/19/2011 | EP1548442B1 Method of diagnosing cancer by detecting gpc3 |
01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
01/19/2011 | EP1132475B1 Novel serine protease bssp2 |
01/19/2011 | CN101952442A Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
01/19/2011 | CN101952426A Anti-BST2 antibody |
01/19/2011 | CN101952414A Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) |
01/19/2011 | CN101952319A Anti-mesothelin antibodies and uses therefor |
01/19/2011 | CN101952318A Anti-NR10 antibody, and use thereof |
01/19/2011 | CN101952317A Humanized anti-human NKG2A monoclonal antibody |
01/19/2011 | CN101952316A Cadherin-11 ECl domain antagonists for treating inflammatory joint disorders |
01/19/2011 | CN101952315A Agents targeting CD138 and uses thereof |
01/19/2011 | CN101952314A Biokinetics of fast-clearing polypeptides |
01/19/2011 | CN101952313A 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
01/19/2011 | CN101952312A Multispecific epitope binding proteins and uses thereof |
01/19/2011 | CN101952311A G immunoglobulin used against anthrax toxins |
01/19/2011 | CN101952310A Methods of inhibiting viral infection |
01/19/2011 | CN101951955A Pharmaceutical composition for cancer treatment |
01/19/2011 | CN101951954A Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
01/19/2011 | CN101951948A Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
01/19/2011 | CN101951885A Formulation |
01/19/2011 | CN101949940A Detection kit of cow milk progesterone content |
01/19/2011 | CN101949937A Time-resolved fluorescence (TRF) immunized detection kit of ovarian cancer tumor marker HE4 |
01/19/2011 | CN101949936A Colloidal gold test strip for detecting antibodies against akabane virus and preparation method thereof |
01/19/2011 | CN101949935A HE4 (Human Epididymis Protein) monoclonal and polyclonal antibody preparation and development of corresponding diagnostic reagent kit |
01/19/2011 | CN101949934A Early infection detection kit of monoclonal antibody-mediated pig pleuropneumoniae |
01/19/2011 | CN101949925A Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method |
01/19/2011 | CN101949921A Heavy metal enzyme label and application thereof |
01/19/2011 | CN101948841A Epitope sequences |
01/19/2011 | CN101948808A Antibody capable of resisting heavy metal mercury ions and application thereof |
01/19/2011 | CN101948807A Heavy metal mercury ion antibody and application thereof |
01/19/2011 | CN101948542A Nanoliposome antivenom active enzyme A2 and enteropathogen specific composite IgY and application thereof |
01/19/2011 | CN101948541A Compositions and methods for the diagnosis and treatment of tumor |
01/19/2011 | CN101948540A Preparation of novel anti-EGFR human source antibody MIL27 and application thereof |
01/19/2011 | CN101948539A IL-18 binding proteins |
01/19/2011 | CN101948538A Method for refining chicken egg yolk antibodies against Escherichia coli |
01/19/2011 | CN101948537A Method for extracting chicken yolk antibody against infectious bursal disease |
01/19/2011 | CN101948536A Porcine transmissible gastroenteritis virus (PTGEV) and porcine epidemic diarrhea virus (PEDV) dual yolk antibody and preparation method thereof |
01/19/2011 | CN101948535A Method for separating immunoglobulin IgY from chicken blood |
01/19/2011 | CN101948534A Method for screening antibodies |
01/19/2011 | CN101948532A Naphthalene artificial immunogen NA-BSA and preparation method and application thereof |
01/19/2011 | CN101948513A L27e family protein antigen epitope, antibody and application thereof |
01/19/2011 | CN101948511A Papain antigenic epitope, antipain antibody and applications of papain antibody |
01/18/2011 | US7872113 Nucleic acids encoding antibodies that bind interleukin-4 receptor |
01/18/2011 | US7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
01/18/2011 | US7872106 Sclerostin-binding antibodies |
01/18/2011 | US7872105 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits |
01/18/2011 | US7872104 Antibody, immunoassay and method for prostate cancer detection |
01/18/2011 | US7872103 Modulating immune responses |
01/18/2011 | US7872102 Anti-IL-23 antibodies |
01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
01/18/2011 | US7871782 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
01/18/2011 | US7871622 Stably tethered structures of defined compositions with multiple functions or binding specificities |
01/18/2011 | US7871621 Anti-HBs monoclonal antibody |
01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
01/18/2011 | US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents |
01/18/2011 | US7871617 Von Willebrand's factor (VWC); transforming growth factors, bone morphongenic proteins as cofactors; monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
01/18/2011 | US7871615 Humanized antibodies that recognize beta amyloid peptide |